BOSTON–What will the Future of Health look like? The topic of health has never been more important than right now. Join TiECON East panelists on Oct. 1 as they discuss the key questions on everyone’s mind:
Do you wonder how the Hospitals of Tomorrow will look and operate in 2031, and how we should manage change with healthcare equity in mind?
Are you curious about the Future of Clinical Trials, and how innovators big and small can accelerate/shape the path to impact?
Do you want to learn more about Winning Business Models in Healthcare AI – what works and why? If you answered yes to any of the above, you will find the Future of Health track fascinating.
The annual TiECON East conference, which is organized by TiE Boston and scheduled for Oct. 1, 2021 at the Westin Hotel in Waltham, MA, is the largest conference of and for entrepreneurs and business executives in the Northeast.
Major sponsors of the conference are Amazon, Microsoft, Vertex Pharmaceuticals, Arent Fox, Converge, Sittercity, Innospark, Thread Research, Progress and Embark.
Here are the panelists speaking in the second of four tracks at TiECON East:
Hospitals of Tomorrow
With all that has transpired in healthcare since 2019, one of the key learnings has been that we can change. The past 16 months especially have shown that data and innovation powered by AI/ML/Deep Tech and other modern technologies can truly accelerate the pace of that change. With that hindsight let’s talk about how we can use that learning to make our hospitals look and operate like they should in 2031. TiECON panelists come from different parts of the healthcare spectrum and will speak to their vision for healthcare in the Hospitals of Tomorrow session.
MODERATOR Lesley Solomon
Venture Chair, Redesign Health
Adam Landman, MD
Chief Information & Digital Innovation Officer Brigham and Women’s Hospital
Amy Flaster
Chief Medical Officer Concerto Care
Frantz Berthaud
Administrative Director, Disease Center Operations, Perygee
Future of Clinical Trials
In the last few years, inspiring innovations have reshaped how we study disease, and prepare for medicine and technologies to manage disease. Clinical trials determine the pace of, access to and efficacy for our Rx and Tx – how should the ecosystem shape its path for the next few years? In this session, the panel shall discuss: how far we’ve come in Clinical Trials thanks to Digital Health; the importance of the next few years – missing technologies needed to shape critical levers, including new digital endpoints, digital phenotyping, diversity and inclusion in trials and more; a de-risking Digital for Clinical Trials – how innovators small and big can accelerate the path to impact.
MODERATOR Varun Ramdevan
Global Digital Innovation Lead, Johnson & Johnson Innovation
Arif Sorathia
Entrepreneur In Residence Route 66 Ventures
AI can significantly improve the quality and cost of health care. But as technologists and entrepreneurs come up with new offerings, they need to think about not only the value their AI can create in healthcare but also the business models that will enable them to capture value. Our panelists will speak from experience about the obstacles that AI businesses face in healthcare and how specific adaptations to business models can help overcome these challenges.
MODERATOR Nikhil Bhojwani
Co-Founder and Managing Partner, Recon Strategy® LLC
Rajni Aneja
Head Digital Medicine ValoHealth
Maya Said
President & CEO Outcomes4Me Inc.
Trishan Panch
Co-founder & Chief Innovation Officer, President Wellframe
